Plasma cell myeloma
Not recruitingStudy on the Effectiveness of Bortezomib, Melphalan, and Prednisone vs. Carfilzomib, Lenalidomide, and Dexamethasone in Older Adults with Newly Diagnosed Multiple Myeloma
Study on the Effectiveness of Bortezomib, Melphalan, and Prednisone vs. Carfilzomib, Lenalidomide, and Dexamethasone in Older Adults with Newly Diagnosed Multiple Myeloma
- Disease:Plasma cell myeloma
- Substances:BortezomibCarfilzomib+5
Spain- Participants:65+ years
- Substances:Bortezomib
- Sponsor:Fundacion PETHEMA
